The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Cash received in acquisition | 0 |
| Acquisition of property and equipment | 0 |
| Investment in securities | 0 |
| Net cash used in investing activities from continuing operations | 0 |
| Net cash provided by investing activities from discontinued operations | 0 |
| Net cash provided by investing activities | 0 |
| Impairment of investment | 0 |
| Net loss from continuing operations | -43,507,142 |
| Depreciation expense | 2,000 |
| Change in fair value of warrant liability | -909,020 |
| Loss on conversion of note payable | -53,446 |
| Loss on disposition of subsidiaries | -214,486 |
| Stock-based compensation | 2,068,892 |
| Common stock issued for services | 4,310,090 |
| Amortization of debt discount | 3,161,100 |
| Amortization of right-of-use assets | 35,935 |
| Interest income | 250,000 |
| Accounts receivable, net | 720,222 |
| Prepaid expenses and deposits | 193,023 |
| Inventory | 213,408 |
| Other receivables | 80,469 |
| Lease liability | -36,979 |
| Accounts payable | -1,567,215 |
| Accrued liabilities | -248,574 |
| Current liabilities | -5,441 |
| Amortization of intangible assets | 453,846 |
| Change in fair value of derivative liability | 2,296,834 |
| Goodwill impairment | 26,346,050 |
| Net cash used in operating activities from continuing operations | -13,382,482 |
| Net cash provided by (used in) operating activities from discontinued operations | 2,799 |
| Net cash used in operating activities | -13,379,683 |
| Net cash used in financing activities from discontinued operations | 0 |
| Repayment of contingent liability | 0 |
| Proceeds from issuance of convertible notes, net of issuance costs | 0 |
| Cash dividends paid | 0 |
| Proceeds from exercise of warrants | 0 |
| Proceeds from exercise of options | 0 |
| Proceeds from loan payable, related party | 116,000 |
| Repayment of loan payable, related party | 531,000 |
| Proceeds from convertible notes | 3,500,000 |
| Repayment of convertible notes | 9,244,444 |
| Gross proceeds from issuance of common stock | 26,293,039 |
| Repayment of development liability | 400,000 |
| Net cash provided by (used in) financing activities from continuing operations | 19,733,595 |
| Net cash provided by (used in) financing activities | 19,733,595 |
| Net change in cash | 6,353,912 |
| Net change in cash | 6,353,912 |
| Cash at beginning of period | 308,096 |
| Cash at end of period | 6,662,008 |
Scienture Holdings, Inc. (SCNX)
Scienture Holdings, Inc. (SCNX)